Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed vs Gefitinib in Advanced NSCLC
NCT01783834Phase 2Completed
- Sponsor
- Gachon University Gil Medical Center
- Start
- Feb 2008
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Pemetrexed Arm with Gefitinib Arm (2 arms). Primary endpoint: Overall Response Rate at 5 years. Started Feb 2008; status: completed.
02
Drugs
pemetrexedgefitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01783834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783834.